<?xml version="1.0" encoding="UTF-8"?>
<def-list list-content="abbreviations" id="cas14811-lp-0001">
 <title>Abbreviations</title>
 <def-item>
  <term>AE</term>
  <def>
   <p>adverse event</p>
  </def>
 </def-item>
 <def-item>
  <term>CI</term>
  <def>
   <p>confidence interval</p>
  </def>
 </def-item>
 <def-item>
  <term>CT</term>
  <def>
   <p>computed tomography</p>
  </def>
 </def-item>
 <def-item>
  <term>EPNEC</term>
  <def>
   <p>extrapulmonary neuroendocrine carcinoma</p>
  </def>
 </def-item>
 <def-item>
  <term>IHC</term>
  <def>
   <p>immunohistochemistry</p>
  </def>
 </def-item>
 <def-item>
  <term>LCNEC</term>
  <def>
   <p>large‐cell neuroendocrine carcinoma</p>
  </def>
 </def-item>
 <def-item>
  <term>MGMT</term>
  <def>
   <p>O
    <sup>6</sup>‐methylguanine DNA methyltransferase
   </p>
  </def>
 </def-item>
 <def-item>
  <term>NEC</term>
  <def>
   <p>neuroendocrine carcinoma</p>
  </def>
 </def-item>
 <def-item>
  <term>NEN</term>
  <def>
   <p>neuroendocrine neoplasm</p>
  </def>
 </def-item>
 <def-item>
  <term>NET</term>
  <def>
   <p>neuroendocrine tumor</p>
  </def>
 </def-item>
 <def-item>
  <term>OS</term>
  <def>
   <p>overall survival</p>
  </def>
 </def-item>
 <def-item>
  <term>PFS</term>
  <def>
   <p>progression‐free survival</p>
  </def>
 </def-item>
 <def-item>
  <term>PS</term>
  <def>
   <p>performance status</p>
  </def>
 </def-item>
 <def-item>
  <term>RR</term>
  <def>
   <p>response rate</p>
  </def>
 </def-item>
 <def-item>
  <term>TMZ</term>
  <def>
   <p>temozolomide</p>
  </def>
 </def-item>
</def-list>
